Pediatrix Medical (PDX) Reports In-Line Q3; Guides
Pediatrix Medical Group, Inc. (NYSE: PDX) reports Q3 EPS of $0.81, in-line with the consensus of $0.81. Revenues came in at $267.2 million, versus the consensus of $258.8 million.
Sees Q4 EPS of $0.77-$0.81, versus the consensus of $0.82.
Pediatrix Medical Group, Inc. provides neonatal, maternal-fetal, other pediatric subspecialty, and anesthesia physician services in the United States and Puerto Rico.
Sees Q4 EPS of $0.77-$0.81, versus the consensus of $0.82.
Pediatrix Medical Group, Inc. provides neonatal, maternal-fetal, other pediatric subspecialty, and anesthesia physician services in the United States and Puerto Rico.
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- Toro Co. (TTC) Tops Q1 EPS by 13c; Guides FY12 EPS Above Views; to Split Stock
- Patterson Companies, Inc. (PDCO) Tops Q4 EPS by 5c; Guides FY12
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
